Ningxia Zhongke Biotechnology Co., Ltd. (600165.SS) SHH

3.58

+0.03(+0.85%)

Updated at October 20 11:29AM

Currency In CNY

Valuation

Market Cap1.66B
Enterprise Value1.88B
P/E Ratio-8.49
PEG Ratio-0.18
Price/Sales Ratio5.43
Price/Book Ratio-24.39
Enterprise/Revenue6.33
Enterprise/EBITDA-11.3

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.64
Operating Margin-0.56

Management Effectiveness

Return On Assets-0.12
Return On Equity3.08

Income Statement

Revenue345.32M
Revenue/Share0.66
Gross Profit-67.47M
EBITDA-306.27M
Net Income-538.91M
Diluted EPS-0.79

Balance Sheet

Total Cash76.63M
Total Cash/Share0.11
Total Debt477.21M
Total Debt/Equity-4.81
Current Ratio0.2
Book Value Per Share0.07

Price History

52-Week Change85.86
52-Week High5.4
52-Week Low1.77
Moving Average 50 Days3.91
Moving Average 200 Days4.11

Statistics

Average Volume9.88M
Shares Outstanding684.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor5:2
Last Split DateNovember 19, 2015